New hope for boosting energy in sickle cell patients
NCT ID NCT07282210
Summary
This study is testing whether a daily pill called SIL-8301 can improve anemia (low red blood cell count) in people with sickle cell disease who are already taking the standard medication hydroxyurea. About 105 participants, aged 16-35, will take either the study drug or a placebo daily for up to 24 weeks while continuing their usual hydroxyurea. Researchers will measure changes in hemoglobin levels, markers of red blood cell destruction, walking ability, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.